Michele Stone

Michele Stone

Company: Kriya Therapeutics

Job title: VP,
Translational Development

Seminars:

Considerations for Nonclinical Study Designs and Model Selection for Metabolic Disease with Existing Treatment Options 1:30 pm

Selection of animal models that support translatability to clinical outcomes Defining efficacy and safety parameters that support risk benefit of a given therapeutic Defining the optimal animal models and study designs that establish both the efficacy and safety endpoints needed to support clinical dose selectionRead more

day: Day Two

PANEL DISCUSSION: Addressing Treatment of Adult vs Pediatric Populations in Metabolic Disease 11:15 am

Designing appropriate clinical trials and clinical endpoints based on disease progression Understanding different study designs and how they need to be adapted based on age of participants What are the key differences in pediatric vs adult populations in gene therapy?Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.